News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,830 Results
Type
Article (8058)
Company Profile (140)
Press Release (476631)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166813)
Career Advice (306)
Deals (25749)
Drug Delivery (7)
Drug Development (52892)
Employer Resources (15)
FDA (9762)
Job Trends (8585)
News (238263)
Policy (17911)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33168)
ALS (105)
Alzheimer's disease (977)
Antibody-drug conjugate (ADC) (264)
Approvals (10380)
Artificial intelligence (321)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6961)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (510)
Cancer (3652)
Cardiovascular disease (218)
Career advice (246)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (479)
Cervical cancer (34)
Clinical research (47879)
Collaboration (1246)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (765)
CRISPR (63)
C-suite (752)
Cystic fibrosis (85)
Data (5661)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (344)
Diagnostics (4190)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73720)
Editorial (1)
Employer branding (2)
Employer resources (15)
Events (87630)
Executive appointments (701)
FDA (12400)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (920)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (291)
Government (946)
Grass and pollen (2)
Guidances (281)
Healthcare (9323)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (953)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12389)
IRA (2)
Job creations (1976)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Labor market (1)
Layoffs (60)
Legal (5196)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (251)
Machine learning (27)
Management (3)
Manufacturing (538)
Marketing (8)
MASH (118)
Medical device (8659)
Medtech (8804)
Mergers & acquisitions (14393)
Metabolic disorders (709)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1827)
NextGen: Class of 2026 (3152)
Non-profit (842)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (197)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (508)
Peanut (31)
People (41260)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15471)
Phase 2 (21385)
Phase 3 (14403)
Pipeline (7344)
Policy (18)
Postmarket research (1570)
Preclinical (6543)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (575)
Real estate (3038)
Recruiting (7)
Regulatory (14832)
Reports (21)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (6)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Tariffs (2)
Vaccines (323)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (47)
Last 7 days (214)
Last 30 days (1582)
Last 365 days (19041)
2026 (12343)
2025 (19257)
2024 (22989)
2023 (26541)
2022 (34603)
2021 (37197)
2020 (33502)
2019 (23291)
2018 (17500)
2017 (18770)
2016 (17923)
2015 (24270)
2014 (21681)
2013 (18138)
2012 (20222)
2011 (20447)
2010 (20332)
Location
Africa (228)
Alabama (74)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17919)
Australia (2100)
California (11991)
Canada (3149)
China (524)
Colorado (485)
Connecticut (409)
Delaware (208)
Europe (24675)
Florida (1791)
Georgia (381)
Hawaii (3)
Idaho (46)
Illinois (701)
India (51)
Indiana (315)
Iowa (15)
Japan (404)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7863)
Michigan (308)
Minnesota (560)
Mississippi (5)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2621)
New Mexico (12)
New York (2822)
North Carolina (1284)
North Dakota (4)
Northern California (6003)
Ohio (278)
Oklahoma (14)
Oregon (18)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4984)
Tennessee (121)
Texas (1942)
United States (38912)
Utah (360)
Vermont (1)
Virginia (155)
Washington D.C. (38)
Washington State (929)
West Virginia (2)
Wisconsin (73)
Wyoming (1)
484,830 Results for "diosynth inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Jacobs Selected to Support Delivery of $1.2B Expansion of FUJIFILM Diosynth Biotechnologies’ Large-Scale Biologics Manufacturing Site
Jacobs was selected by FUJIFILM Diosynth Biotechnologies to support delivery of $1.2 billion expansion of an end-to-end, large-scale cell culture contract manufacturing site in Holly Springs, North Carolina.
June 27, 2024
·
4 min read
Press Releases
FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-Year U.S. Manufacturing Agreement Valued at Over $3 Billion
April 22, 2025
·
5 min read
Deals
FUJIFILM Diosynth Biotechnologies: There’s a New Cell Therapy Employer in Thousand Oaks
FUJIFILM Diosynth Biotechnologies is offering unique opportunities to join one of the top global CDMOs focused on solving some of the most complex healthcare challenges.
December 2, 2022
·
5 min read
·
Heather McKenzie
Bio NC
FUJIFILM Diosynth Biotechnologies Enters Into an Agreement with Argenx to Manufacture Efgartigimod, a monoclonal antibody (mAb) for the Treatment of Severe Autoimmune Diseases
FUJIFILM Diosynth Biotechnologies announced an agreement with argenx to manufacture efgartigimod, a monoclonal antibody fragment to target the neonatal Fc receptor, in patients with severe autoimmune disease.
October 27, 2022
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Fujifilm Diosynth Opening Viral Vector Manufacturing Plant Near Boston
The new process development and manufacturing facility will focus on viral vectors and advanced therapies. It is the third location for Diosynth’s CDMO viral vector services.
January 5, 2021
·
3 min read
·
Mark Terry
Business
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
Chimeron Bio, today announced it has entered into a manufacturing agreement with FUJIFILM Diosynth Biotechnologies (FDB), a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and viral gene therapies, to advance the Company’s Oncology portfolio to the clinic.
April 12, 2022
·
3 min read
Business
aTyr Pharma and FUJIFILM Diosynth Biotechnologies Announce Manufacturing Agreement for aTyr’s Lead Therapeutic Candidate ATYR1923
aTyr Pharma, Inc. (Nasdaq: LIFE), and FUJIFILM Diosynth Biotechnologies, today announced a manufacturing agreement for ATYR1923, aTyr Pharma’s lead therapeutic candidate that is currently in clinical development for pulmonary sarcoidosis, a major form of interstitial lung disease (ILD).
November 30, 2021
·
6 min read
Business
LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies Announce Collaboration to Support Development and Manufacturing of Gene Therapies for Genetic Diseases
LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies today announced a strategic collaboration to support the development and manufacturing of LEXEO’s AAV-mediated gene therapies.
October 13, 2021
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 48,483
Next
